Health and Medicine

GPCRs-targeted drug discovery continues to gain exponential momentum, with advances in screening tools, characterization of dynamic confirmations and basic GPCR biology, including orphan receptors. Coupled with numerous strategic collaboration and investment, the GPCR field is fuelling for the clinical progression of next-generation small molecules and biologics across a spectrum of indications and previously undrugged GPCR targets. Owing to this, the Annual GPCRs-Targeted Drug Discovery Summit returns for its 3rd year as the world's only and most comprehensive industry dedicated GPCR forum. Bringing two brand new specialized tracks of content (Target ID and Validation and Hit ID and Optimization), don't miss…

This interactive 30-hour course provides an introduction to single-use systems (SUS) in the biopharmaceutical industry, covering methods, requirements, and emerging trends in licensed biopharmaceutical therapeutics. Participants will gain a solid understanding of current good manufacturing practice (cGMP) guidelines, SUS application, and different types of SUS. The course will explore the fundamentals of biopharmaceutical production and provide attendees with the knowledge necessary to produce human therapeutics.

This forthcoming conference follows the success of the past eleven AAVM conferences held in Helsinki, Ottawa, Orlando, Prague, Tel Aviv, Washington DC, Berlin, Budapest, Rome and Madrid, as well as one held online during the COVID lockdown period. Antimicrobials are still critically important and necessary in farm and companion animal therapy, notwithstanding the increased attention and measures to promote an overall reduced and responsible use. The risk for the spread of bacterial resistance when antimicrobials are used is well known, and the interconnection of use of animal and human antimicrobials further increases the concern for human and animal health. Alternatives…

Antibody-drug conjugates are coming of age with a remarkable surge in recent times, which has marked a turning point in their development. Notable achievements include the ground-shaking triumph of ENHERTU, eye-popping investments like Pfizer's monumental $43 billion acquisition of Seagen, and the FDA's greenlight for ELAHERE. These milestones have transformed the ADC landscape, driving increased interest and investment in the field, which now has a preclinical and clinical arena dynamically evolving. As such, the 14th World ADC London returns next March. This will be the first opportunity in the new year to explore these monumental wins, reflect on ongoing challenges,…

Gain knowledge on the latest recommendations involving medical specialties important to the urgent care setting that can be immediately applied into practice. Mayo Clinic's Urgent Care Updates course is designed for the acute/urgent care provider and uses relevant lectures along with panel and roundtable discussions to provide opportunities to interact with faculty. URL: Tickets: https://go.evvnt.com/2051772-0?pid=154 Prices: MD/PHD: USD 950.00, Allied Health, NP, PA, Nurse, Retiree: USD 825.00 Category: Conferences | Science, Health and Medicine | CME (Continuing Medical Education) Date and Time: 25th April 2024 at 6:30 am to 12:05 pm

With new clinical data and more ground-breaking advancements in the technology underpinning microbiome research, Europe's leading microbiome organisations are paving the way for drug development! Join us at the 8th Microbiome Movement- Drug Development Summit Europe where we will cover the most exciting progress in the microbiome world, from expanded analytics and larger-scale manufacturing to the most pressing challenges from translation to regulations. In January, 150+ microbiome innovators will be united in Barcelona for the flagship meeting for European microbiome-based therapeutic developers. We are bringing together microbiome trailblazers across industry, academia and investors to share their insights across autoimmune disorders,…

The 5th Glioblastoma Drug Development Summit is the only industry led forum for large pharma, biotech, neuro-oncologists and academic KOLs to unite alongside a dedicated panel of investors under the common goal to breakthrough GBM barriers to accelerate the practical translation and clinical development of emerging therapeutics for glioblastoma and CNS tumor patients. Discover innovative approaches to surpassing the blood-brain barrier to unlock previously uncovered therapeutic potential, keep ahead of the latest clinical trial design rationale and navigate the regulatory landscape for novel combination therapies with actionable insights to improve clinical success. With promising clinical readouts from a range of…

PepTalk 2024 will offer a comprehensive program presenting the latest research and development in the field of protein science and production. Featuring world-class presentations, poster sessions, keynotes, breakout groups, panel discussions, training seminars, exhibitions and demonstrations, and invaluable networking with leading researchers and global industry pioneers.

The Innate Killer Summit is returning for the 9th year as the must-attend meeting for the NK community, committed to addressing the critical challenges across all NK-targeted therapeutic types. Join this focused, collaborative forum spanning Preclinical, Clinical Translation and CMC and Process development to brainstorm with industry pioneers on the best approaches to enhance efficacy and persistence as well as reduce the cost of production. Showcasing innovation across biopharma and academia, we have collaborated with MD Anderson, Replay Bio, Pfizer, Glycostem, Senti Bio, XNK Therapeutics, Sanofi, Zelluna Immunotherapy and many more to uncover translational lessons learned in liquid and solid…

The last 12 months have highlighted key milestones in European biopharma investment– from GSK injecting €1 million into a 15-building biotech campus in Stevenage, to AstraZeneca investing £1 billion into a new R AND D and Corporate HQ. As the pressure to expand and continue pipeline progression within a scattered and distributed market, there has never been a better time to know how to navigate unknown waters. Emulating the 2023 success, the Lab Asset and Facility Management in Pharma Europe returns for the second year running. This expert-led summit is solely dedicated to imparting expert knowledge with the goal of…

Accelerate patient value. Pioneer healthcare's transformation. Healthcare reforms are finally paving the way to affordable access to medicines, yet this progress threatens the development of future life-saving therapies. The moment is now to prove ourselves as a trusted industry ally and the ultimate safe harbor for patients. The key? Delivering aligned value to HCPs, patients, payers and regulators. Speed and scale is non-negotiable. Those afraid to accelerate will be left behind. We must adapt to evolving payer needs, empower HCPs with crucial insights, bridge regulatory gaps and co-create with patients. Only then will we achieve exceptional outcomes. Reuters Events: Pharma…

Mayo Clinic Psychiatry's flagship course, Psychiatry Clinical Updates, is aimed at providing clinically relevant updates for the management of psychiatric problems and their comorbidities across the lifespan. Topics include updates and clinical pearls on mood and psychotic disorders, anxiety, trauma, addiction, and perinatal psychiatry, as well as evidence-based psychotherapy and emerging pharmacotherapies. The course takes place February 26-29, 2024. POST-COURSE SESSION Join us on March 1, 2024, for a bonus day of content! Psychiatry in Medical Settings covers the special challenges of diagnosing and treating psychiatric and psychological problems in patients with major medical-surgical illnesses including cancer, heart disease, and…

Mayo Clinic's OB/GYN practice has more than a 30-year history of conducting innovative and transformational courses for providers in obstetrics, gynecology, family medicine, internal medicine, and women's health. We are pleased to offer our sixth annual enterprise-wide clinical and surgical OB/GYN course drawing leading experts from Mayo Clinic Arizona, Florida, Rochester, and Mayo Clinic Health System. Live and livestream options available. **New for 2024, join for an extra day of programming on the role of coaching in medicine and surgery (additional information below) Highlights encompassing all areas of OBGYN include practical talks, specifically: -Contemporary management of obesity -Preparing for cesarean…

This conference will be continuing with debates as well as adhering to the format of the previous conferences which are designed to provide an in-depth progress report on new antiepileptic drugs in various stages of development, as well as to present new findings on second-generation treatments. All persons related to the field are invited to attend. URL: Tickets: https://go.evvnt.com/2046181-0?pid=154 Time: 3:00 PM - 1:30 PM Price: General Admission: EUR 650.00

The 8th CoBrCa Congress will continue to directly address key and controversial issues facing clinicians in their daily practice in an effort to find solutions to unresolved clinical and therapeutic problems. Experts, from different disciplines, from all over the world will debate, discuss, and present lectures on topics in medical oncology, surgery, breast imaging, radiation oncology, pathology, reconstruction and more. At the end of each lecture, the participants will be provided with ample time to join the discussion. URLs: Twitter: https://go.evvnt.com/2045956-0?pid=154 LinkedIn: https://go.evvnt.com/2045956-2?pid=154 LinkedIn: https://go.evvnt.com/2045956-3?pid=154 Instagram: https://go.evvnt.com/2045956-5?pid=154 Prices: Physicians and Scientists (ABS Member): GBP 630.00, Physicians and Scientists (Non-Member): GBP…

Pharma's role within the healthcare system is weakening. Increased demand, economic strains, suffocating regulatory change and a widening access gap is impacting future pipelines and commercial innovations reaching patients. Internally, siloed functions too often compete instead of complementing each other. Failing to rally behind a common purpose and secure a future where better medicines and an aligned value proposition reaches our patients, payers, policy makers, HTAs and customers. No one function can do this alone, we must act as one. That's why over 1,200 of the world's leading pharma changemakers from commercial, marketing, medical affairs, patient engagement, market access, RWE,…

Significant advances in the diagnosis and management of heart failure and arrhythmias continue to emerge, compelling the practice of cardiology to constantly evolve. These advances must be consistently implemented into clinical practice to guarantee the best care for patients affected by these cardiovascular conditions. The Clinical Advances in Heart Failure, Arrhythmias, and Cardiogenic Shock Symposium is designed to assist clinicians in correctly diagnosing, treating, and managing patients with arrhythmias and heart failure as well as optimally managing those with cardiogenic shock. The symposium is dedicated to providing insight and practical tips with regard to integrating scientific evidence into clinical practice.…

Attended and convened with the key opinion leaders in Organ modelling, 3D cell culture and mimics, these events address an important and expanding field in drug development. Organ-on-a-Chip, Tissue-on-a-Chip & Organoids are remarkable tools with the potential that better predict drug efficacy and thereby reduce cost, time, and failure rates in clinical trials. drug response.? Together with the 3D Cell Culture, attendees will also benefit from insightful case studies exploring key trends and innovative technologies to accelerate the adoption of 3D models in preclinical research via advanced development, validation and application strategies.

SAE Media Group is proud to present the 3rd annual Transdermal and Microneedle Drug Delivery Conference. This unique forum will bring together expertise from senior representatives across big pharma, biotechs, associations and regulatory bodies to explore the latest developments in transdermal drug delivery and microneedle design. Key themes include: Therapeutic applications Innovations and development in microneedle technology and industry MAP Vaccination - Breakthrough in the Gambia MAP Vaccination - Revolutionising global health MAP Vaccination - Entrenching and expanding needle-free delivery Looking ahead - Approaching universal challenges The two-day agenda offers you peer-to-peer networking with CEO's, Senior Vice presidents, Directors, Heads…

Imaging and Decision-Making in Cartilage-Regenerative Surgery Advanced Imaging Technology in radiology, particularly Magnetic Resonance Imaging, has emerged during the last decades and has always been the focus of cartilage repair. The proper treatment indication before surgery and a relevant noninvasive evaluation of the outcome after surgery is essential and can be strongly supported by noninvasive imaging. Additionally, imaging can evaluate and monitor the efficacy of newly developed surgical cartilage repair techniques. The semiquantitative MOCART Score was developed in Vienna 20 years ago and was a hallmark in the systematic morphological analysis of cartilage repair. Moreover, new compositional MR methods such…